Nic-Hit
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80059877
- Status
- Active licence
- Licence date
- 13 April 2015
- Revision date
- 26 February 2025
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-propénoïque, 2-méthyl-, Polymère avec du diéthénylbenzène, mélangé avec de la 3-((2S)-1-méthyl-2-pyrrolinidinyl)pyridine Source : Nicotine polacrilex | 2 milligramme |
Non-medicinal ingredients
Coconut Oil, Glycosides de stéviol, Talc, gomme acacia, Stéarate de magnésium, xylitol, Poly(alcool vinylique), Carboxyméthylcellulose, Caprylate de glycéryle/Caprate, D-Mannitol, Amidon de maïs, Saveur, Lauryl sulfate de sodium, Dioxyde de titane, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Pastille | minimum: 3 days ; maximum: 15 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Stop smoking aid. Nic-Hit lozenges can help you stop smoking by reducing withdrawal symptoms, including nicotine cravings associated with quitting smoking. To be used as part of a comprehensive smoking cessation program.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80059877
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.